CDXC

ChromaDex Corporation

2.60 USD
+0.05 (+1.96%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ChromaDex Corporation stock is down -16.67% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 8 June’s closed higher than May. 100% of analysts rate it a buy.

About ChromaDex Corporation

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. It researches on nicotinamide adenine dinucleotide (NAD+) and develops and commercializes proprietary-based ingredient technologies. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform.